Dermata Therapeutics, Inc. (DRMA) NASDAQ
1.19
-0.05(-4.03%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
1.19
-0.05(-4.03%)
Currency In USD
| Market Cap | 206,550 |
| Enterprise Value | -2.96M |
| P/E Ratio | -0.14 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.31 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.44 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.74 |
| Return On Equity | -1.92 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -12.29M |
| Net Income | -12.29M |
| Diluted EPS | -80.32 |
| Total Cash | 4.66M |
| Total Cash/Share | 4.54 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 4.56 |
| Book Value Per Share | 3.86 |
| 52-Week Change | 0 |
| 52-Week High | 23.7 |
| 52-Week Low | 1.11 |
| Moving Average 50 Days | 1.81 |
| Moving Average 200 Days | 4.25 |
| Average Volume | 2.15M |
| Shares Outstanding | 681,557 |
| % Held by Institutions | 38.16 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | August 01, 2025 |